|
Li K, Anderson G, Viallon V, Arveux P, Kvaskoff M, Fournier A, Krogh V, Tumino R, Sánchez MJ, Ardanaz E, Chirlaque MD, Agudo A, Muller DC, Smith T, Tzoulaki I, Key TJ, Bueno-de-Mesquita B, Trichopoulou A, Bamia C, Orfanos P, Kaaks R, Hüsing A, Fortner RT, Zeleniuch-Jacquotte A, Sund M, Dahm CC, Overvad K, Aune D, Weiderpass E, Romieu I, Riboli E, Gunter MJ, Dossus L, Prentice R, Ferrari P. Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts. Breast Cancer Res. 2018 Dec 3;20(1):147. doi: 10.1186/s13058-018-1073-0. PubMed PMID: 30509329; PubMed Central PMCID: PMC6276150.
AÑO: 2018; IF: 5.676
|
30509329
|
Villanueva CM, Gracia-Lavedan E, Bosetti C, Righi E, Molina AJ, Martín V, Boldo E, Aragonés N, Perez-Gomez B, Pollan M, Acebo IG, Altzibar JM, Zabala AJ, Ardanaz E, Peiró R, Tardón A, Chirlaque MD, Tavani A, Polesel J, Serraino D, Pisa F, Castaño-Vinyals G, Espinosa A, Espejo-Herrera N, Palau M, Moreno V, La Vecchia C, Aggazzotti G, Nieuwenhuijsen MJ, Kogevinas M. Colorectal Cancer and Long-Term Exposure to Trihalomethanes in Drinking Water: A Multicenter Case-Control Study in Spain and Italy. Environ Health Perspect. 2017 Jan;125(1):56-65. doi: 10.1289/EHP155. Epub 2016 Jul 6. PubMed PMID: 27383820; PubMed Central PMCID: PMC5226692.
AÑO: 2017; IF: 8.309
|
|
Agudo A, Peluso M, Munnia A, Luján-Barroso L, Barricarte A, Amiano P, Navarro C, Sánchez MJ, Quirós JR, Ardanaz E, Larrañaga N, Tormo MJ, Chirlaque MD, Rodríguez-Barranco M, Sánchez-Cantalejo E, Cellai F, Bonet C, Sala N, González CA. Aromatic DNA adducts and breast cancer risk: a case-cohort study within the EPIC-Spain. Carcinogenesis. 2017 Jul 1;38(7):691-698. doi: 10.1093/carcin/bgx047. PubMed PMID: 28535209.
AÑO: 2017; IF: 5.072
|
|
Papantoniou K, Castaño-Vinyals G, Espinosa A, Turner MC, Alonso-Aguado MH, Martin V, Aragonés N, Pérez-Gómez B, Pozo BM, Gómez-Acebo I, Ardanaz E, Altzibar JM, Peiro R, Tardon A, Lorca JA, Chirlaque MD, García-Palomo A, Jimenez-Moleon JJ, Ierssen T, Ederra M, Amiano P, Pollan M, Moreno V, Kogevinas M. Shift work and colorectal cancer risk in the MCC-Spain case-control study. Scand J Work Environ Health. 2017 May 1;43(3):250-259. doi: 10.5271/sjweh.3626. Epub 2017 Mar 2. PubMed PMID: 28251241.
AÑO: 2017; IF: 2.792
|
|
Hüsing A, Fortner RT, Kühn T, Overvad K, Tjønneland A, Olsen A, Boutron-Ruault MC, Severi G, Fournier A, Boeing H, Trichopoulou A, Benetou V, Orfanos P, Masala G, Pala V, Tumino R, Fasanelli F, Panico S, Bueno de Mesquita HB, Peeters PH, van Gills CH, Quirós JR, Agudo A, Sánchez MJ, Chirlaque MD, Barricarte A, Amiano P, Khaw KT, Travis RC, Dossus L, Li K, Ferrari P, Merritt MA, Tzoulaki I, Riboli E, Kaaks R. Added Value of Serum Hormone Measurements in Risk Prediction Models for Breast Cancer for Women Not Using Exogenous Hormones: Results from the EPIC Cohort. Clin Cancer Res. 2017 Aug 1;23(15):4181-4189. doi: 10.1158/1078-0432.CCR-16-3011. Epub 2017 Feb 28. PubMed PMID: 28246273.
AÑO: 2017; IF: 10.199
|